相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter
Yaxia Yuan et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Mutations at Tyrosine 88, Lysine 92 and Tyrosine 470 of Human Dopamine Transporter Result in an Attenuation of HIV-1 Tat-Induced Inhibition of Dopamine Transport
Narasimha M. Midde et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding
Scot McIntosh et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
HIV-1 Nef expression in microglia disrupts dopaminergic and immune functions with associated mania-like behaviors
Shaona Acharjee et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
The role of decision-making ability in HIV/AIDS: Impact on prospective memory
Kelly Coulehan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2014)
Mutation of Tyrosine 470 of Human Dopamine Transporter is Critical for HIV-1 Tat-Induced Inhibition of Dopamine Transport and Transporter Conformational Transitions
Narasimha M. Midde et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Aravind Penmatsa et al.
NATURE (2013)
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120
Shuxian Hu et al.
PLOS ONE (2013)
Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse
Amanda N. Carey et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Neurocognitive dysfunction in the highly active antiretroviral therapy era
Nomvuyo Z. Mothobi et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
HIV-1 Tat Protein Decreases Dopamine Transporter Cell Surface Expression and Vesicular Monoamine Transporter-2 Function in Rat Striatal Synaptosomes
Narasimha M. Midde et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context
Hui Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Eradication of HIV from the brain: reasons for pause
Avindra Nath et al.
AIDS (2011)
Current understanding of HIV-associated neurocognitive disorders pathogenesis
Patrick Gannon et al.
CURRENT OPINION IN NEUROLOGY (2011)
Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Shilpa Buch et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2011)
Drugs of Abuse, Dopamine, and HIV-Associated Neurocognitive Disorders/HIV-Associated Dementia
Vishnudutt Purohit et al.
MOLECULAR NEUROBIOLOGY (2011)
Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats
Narasimha M. Midde et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Recombinant Human Immunodeficiency Virus-1 Transactivator of Transcription1-86 Allosterically Modulates Dopamine Transporter Activity
Jun Zhu et al.
SYNAPSE (2011)
Regulation of the dopamine transporter Aspects relevant to psychostimulant drugs of abuse
Kyle C. Schmitt et al.
ADDICTION REVIEWS 2 (2010)
Increased dopaminergic neurotransmission in therapy-na < ve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses
C. Scheller et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization
Mark J. Ferris et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART
Jinsong Peng et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Human Immunodeficiency Virus-1 Tat Activates Calpain Proteases via the Ryanodine Receptor to Enhance Surface Dopamine Transporter Levels and Increase Transporter-Specific Uptake and Vmax
Seth W. Perry et al.
JOURNAL OF NEUROSCIENCE (2010)
Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat
Katy M. Webb et al.
JOURNAL OF NEUROVIROLOGY (2010)
Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers
Pei Chun Hsieh et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine A Bridge between HIV-Associated Neurologic Disorders and Drug Abuse
Peter J. Gaskill et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Methamphetamine-Induced Behavioral Sensitization Is Enhanced in the HIV-1 Transgenic Rat
Xiangqian Liu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains
Adarsh M. Kumar et al.
JOURNAL OF NEUROVIROLOGY (2009)
Nicotinic Receptor Activation Increases [3H]Dopamine Uptake and Cell Surface Expression of Dopamine Transporters in Rat Prefrontal Cortex
Jun Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [H-3]Dopamine Uptake: Dissociation of [H-3]Dopamine Uptake and [H-3]2 beta-Carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes
Jun Zhu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Mechanism for Cocaine Blocking the Transport of Dopamine: Insights from Molecular Modeling and Dynamics Simulations
Xiaoqin Huang et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2009)
Role of Tat Protein in HIV Neuropathogenesis
Wenxue Li et al.
NEUROTOXICITY RESEARCH (2009)
In Vivo Microdialysis in Awake, Freely Moving Rats Demonstrates HIV-1 Tat-Induced Alterations in Dopamine Transmission
Mark J. Ferris et al.
SYNAPSE (2009)
Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse
J. Zhu et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: Evidence for differential regulation in caudate putamen and nucleus accumbens
Devadoss J. Samuvel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Studies of the biogenic amine transporters. 12. Identification of novel partial inhibitors of amphetamine-induced dopamine release
Joseph J. Pariser et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse
Linda Chang et al.
NEUROIMAGE (2008)
Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine
S. B. Harrod et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Neurotoxicity of HIV-1 tat protein: Involvement of D1 dopamine receptor
Janelle M. Silvers et al.
NEUROTOXICOLOGY (2007)
How dopamine transporter interacts with dopamine: Insights from molecular modeling and simulation
Xiaoqin Huang et al.
BIOPHYSICAL JOURNAL (2007)
Cheerful news for antidepressant research
Simon Hadlington
CHEMISTRY WORLD (2007)
Antidepressant binding site in a bacterial homologue of neurotransmitter transporters
Satinder K. Singh et al.
NATURE (2007)
Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression
Jun Zhu et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Identification of a chloride ion binding site in Na+/Cl--dependent transporters
Lucy R. Forrest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism
Lisa S. Middleton et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
The debate over dopamine's role in reward: the case for incentive salience
Kent C. Berridge
PSYCHOPHARMACOLOGY (2007)
Abnormal Striatal Dopaminergic Synapses in National NeuroAIDS Tissue Consortium Subjects with HIV Encephalitis
Benjamin B. Gelman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Neuroimmunity and the Blood-Brain Barrier: Molecular Regulation of Leukocyte Transmigration and Viral Entry into the Nervous System with a Focus on NeuroAIDS
Clarisa M. Buckner et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
BJ Everitt et al.
NATURE NEUROSCIENCE (2005)
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
A Yamashita et al.
NATURE (2005)
Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex
J Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Environmental enrichment enhances sensitization to GBR 12935-induced activity and decreases dopamine transporter function in the medial prefrontal cortex
J Zhu et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Decreased brain dopaminergic transporters in HIV-associated dementia patients
GJ Wang et al.
BRAIN (2004)
A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy
PE Ray et al.
KIDNEY INTERNATIONAL (2003)
Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline
BO Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities
ZC Lin et al.
PHARMACOGENOMICS JOURNAL (2003)
Involvement of dopamine in the progression of AIDS Dementia Complex
E Koutsilieri et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
Striatal dopamine transporters and cognitive functioning in healthy men and women
LH Mozley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction
W Reid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease
SM Kulich et al.
JOURNAL OF NEUROCHEMISTRY (2001)
HIV dementia: the role of the basal ganglia and dopaminergic systems
JR Berger et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2000)
Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures
M Stanciu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues
L Hudson et al.
JOURNAL OF NEUROVIROLOGY (2000)
分享论文
